|
1
|
Burkitt D: A sarcoma involving the jaws in
African children. Br J Surg. 46:218–223. 1958. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Magrath I: Epidemiology: Clues to the
pathogenesis of Burkitt lymphoma. Br J Haematol. 156:744–756. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Epstein MA and Barr YM: Cultivation in
vitro of human lymphoblasts from Burkitt's malignant lymphoma.
Lancet. 1:252–253. 1964. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dave SS, Fu K, Wright GW, Lam LT, Kluin P,
Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, et al:
Molecular diagnosis of Burkitt's lymphoma. N Engl J Med.
354:2431–2442. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qiu J, Cosmopoulos K, Pegtel M, Hopmans E,
Murray P, Middeldorp J, Shapiro M and Thorley-Lawson DA: A novel
persistence associated EBV miRNA expression profile is disrupted in
neoplasia. PLoS Pathog. 7:e10021932011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dalla-Favera R, Bregni M, Erikson J,
Patterson D, Gallo RC and Croce CM: Human c-myc onc gene is located
on the region of chromosome 8 that is translocated in Burkitt
lymphoma cells. Proc Natl Acad Sci USA. 79:7824–7827. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zimonjic DB, Keck-Waggoner C and Popescu
NC: Novel genomic imbalances and chromosome translocations
involving c-myc gene in Burkitt's lymphoma. Leukemia. 15:1582–1588.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Piccaluga PP, De Falco G, Kustagi M,
Gazzola A, Agostinelli C, Tripodo C, Leucci E, Onnis A, Astolfi A,
Sapienza MR, et al: Gene expression analysis uncovers similarity
and differences among Burkitt lymphoma subtypes. Blood.
117:3596–3608. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lenze D, Leoncini L, Hummel M, Volinia S,
Liu CG, Amato T, De Falco G, Githanga J, Horn H, Nyagol J, et al:
The different epidemiologic subtypes of Burkitt lymphoma share a
homogenous micro RNA profile distinct from diffuse large B-cell
lymphoma. Leukemia. 25:1869–1876. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cullen BR: Transcription and processing of
human microRNA precursors. Mol Cell. 16:861–865. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cai X, Schäfer A, Lu S, Bilello JP,
Desrosiers RC, Edwards R, Raab-Traub N and Cullen BR: Epstein-Barr
virus microRNAs are evolutionarily conserved and differentially
expressed. PLoS Pathog. 2:e232006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Skalsky RL, Corcoran DL, Gottwein E, Frank
CL, Kang D, Hafner M, Nusbaum JD, Feederle R, Delecluse HJ, Luftig
MA, et al: The viral and cellular microRNA targetome in
lymphoblastoid cell lines. PLoS Pathog. 8:e10024842012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feederle R, Linnstaedt SD, Bannert H, Lips
H, Bencun M, Cullen BR and Delecluse HJ: A viral microRNA cluster
strongly potentiates the transforming properties of a human
herpesvirus. PLoS Pathog. 7:e10012942011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seto E, Moosmann A, Grömminger S, Walz N,
Grundhoff A and Hammerschmidt W: Micro RNAs of Epstein-Barr virus
promote cell cycle progression and prevent apoptosis of primary
human B cells. PLoS Pathog. 6:e10010632010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vereide DT, Seto E, Chiu YF, Hayes M,
Tagawa T, Grundhoff A, Hammerschmidt W and Sugden B: Epstein-Barr
virus maintains lymphomas via its miRNAs. Oncogene. 33:1258–1264.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanda T, Miyata M, Kano M, Kondo S,
Yoshizaki T and Iizasa H: Clustered microRNAs of the Epstein-Barr
virus cooperatively downregulate an epithelial cell-specific
metastasis suppressor. J Virol. 89:2684–2697. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ambrosio MR, Navari M, Di Lisio L, Leon
EA, Onnis A, Gazaneo S, Mundo L, Ulivieri C, Gomez G, Lazzi S, et
al: The Epstein Barr-encoded BART-6-3p microRNA affects regulation
of cell growth and immuno response in Burkitt lymphoma. Infect
Agent Cancer. 9:122014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hamada S, Satoh K, Miura S, Hirota M,
Kanno A, Masamune A, Kikuta K, Kume K, Unno J, Egawa S, et al:
miR-197 induces epithelial-mesenchymal transition in pancreatic
cancer cells by targeting p120 catenin. J Cell Physiol.
228:1255–1263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Keutgen XM, Filicori F, Crowley MJ, Wang
Y, Scognamiglio T, Hoda R, Buitrago D, Cooper D, Zeiger MA,
Zarnegar R, et al: A panel of four miRNAs accurately differentiates
malignant from benign indeterminate thyroid lesions on fine needle
aspiration. Clin Cancer Res. 18:2032–2038. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Du L, Schvageman JJ, Subauste MC, Saber B,
Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD and
Pertsemlidis A: miR-93, miR-98, and miR-197 regulate expression of
tumor suppressor gene FUS1. Mol Cancer Res. 7:1234–1243. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dai Y, Xie CH, Neis JP, Fan CY, Vural E
and Spring PM: MicroRNA expression profiles of head and neck
squamous cell carcinoma with docetaxel-induced multidrug
resistance. Head Neck. 33:786–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou J, Zhou Y, Yin B, Hao W, Zhao L, Ju W
and Bai C: 5-Fluorouracil and oxaliplatin modify the expression
profiles of microRNAs in human colon cancer cells in vitro. Oncol
Rep. 23:121–128. 2010.PubMed/NCBI
|
|
27
|
Wang T, Zhang X, Obijuru L, Laser J, Aris
V, Lee P, Mittal K, Soteropoulos P and Wei JJ: A micro-RNA
signature associated with race, tumor size, and target gene
activity in human uterine leiomyomas. Genes Chromosomes Cancer.
46:336–347. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dai W, Wang C, Wang F, Wang Y, Shen M,
Chen K, Cheng P, Zhang Y, Yang J, Zhu R, et al: Anti-miR-197
inhibits migration in HCC cells by targeting KAI 1/CD82. Biochem
Biophys Res Commun. 446:541–548. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
DeNardo DG and Coussens LM: Inflammation
and breast cancer. Balancing immune response: Crosstalk between
adaptive and innate immune cells during breast cancer progression.
Breast Cancer Res. 9:2122007. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kishimoto T: The biology of interleukin-6.
Blood. 74:1–10. 1989.PubMed/NCBI
|
|
31
|
Lu LS: Experimental study on IL-6 activity
against tumor: I. Regulation of IL-2-induced LAK cells. Zhonghua
Zhong Liu Za Zhi. 14:250–252. 1992.(In Chinese).
|
|
32
|
Mizutani H, May LT, Sehgal PB and Kupper
TS: Synergistic interactions of IL-1 and IL-6 in T cell activation.
Mitogen but not antigen receptor-induced proliferation of a cloned
T helper cell line is enhanced by exogenous IL-6. J Immunol.
143:896–901. 1989.PubMed/NCBI
|
|
33
|
Muraguchi A, Kishimoto T, Miki Y, Kuritani
T, Kaieda T, Yoshizaki K and Yamamura Y: T cell-replacing factor-
(TRF) induced IgG secretion in a human B blastoid cell line and
demonstration of acceptors for TRF. J Immunol. 127:412–416.
1981.PubMed/NCBI
|
|
34
|
Kishimoto T: Interleukin-6: From basic
science to medicine-40 years in immunology. Annu Rev Immunol.
23:1–21. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peters M, Jacobs S, Ehlers M, Vollmer P,
Müllberg J, Wolf E, Brem G, Büschenfelde KH Meyerzum and Rose-John
S: The function of the soluble interleukin 6 (IL-6) receptor in
vivo: Sensitization of human soluble IL-6 receptor transgenic mice
towards IL-6 and prolongation of the plasma half-life of IL-6. J
Exp Med. 183:1399–1406. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin YS, Lin LC, Huang MH, Huang AJ and
Huang YT: Down-regulation of gp130 in nasopharyngeal carcinoma. Am
J Rhinol Allergy. 23:28–32. 2009. View Article : Google Scholar : PubMed/NCBI
|
